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Much  evidence  supports  the  central 
contribution  of  the  microbiota  to   
intestinal health and disease. Although 
it plays beneficial roles in host develop-
ment, metabolism, and defense, the   
relationship between the microbiota 
and host can break down, culminating 
in IBD. With few exceptions, murine 
models of intestinal inflammation are at-
tenuated in germ-free animals (Strober 
et al., 2002). In humans, both antibiotic 
treatment  and  diversion  of  the  fecal 
stream can similarly attenuate disease   
in some Crohn’s disease (CD) patients 
(Rutgeerts  et  al.,  1991;  Perencevich 
and Burakoff, 2006). CD clinical symp-
toms also tend to develop in the termi-
nal ileum and colon, the sites of the 
intestine with the highest bacterial load 
(Sartor, 2008).
Genetic  association  studies  have 
linked  pattern  recognition  receptors 
(PRRs) that mediate microbial sensing 
with the development of IBD. These 
include  NOD2  and  NLRP3  (Hugot   
et al., 2001; Ogura et al., 2001; Villani 
et al., 2009) as well as multiple TLR 
genes  (De  Jager  et  al.,  2007;  Pierik   
et al., 2006; Török et al., 2004). How-
ever, the functional characterization of 
PRRs  in  IBD  is  just  starting  to  be   
unraveled. Recent studies published in 
this journal (Salcedo et al. [this issue]; 
Allen  et  al.,  2010)  and  elsewhere   
(Dupaul-Chicoine  et  al.,  2010;  Zaki   
et al., 2010) provide fresh insights into 
the regulation of intestinal inflamma-
tion and carcinogenesis by the signaling 
pathways triggered by these innate sen-
sors.  These  studies  also  highlight  the 
diverse functions of microbial sensing 
in intestinal homeostasis.
Epithelial protection
One hallmark of IBD is disruption of 
the intestinal epithelium. Normally, 
maintenance  of  the  intestinal  epithe-
lium  involves  a  dynamic  process  in 
which  intestinal  stem  cells  (ISCs)   
located at the crypt base undergo dif-
ferentiation, proliferation, and migra-
tion along the crypt–villus axis. At the 
end of this journey, intestinal epithelial 
cells (IECs) undergo apoptosis. These 
processes appear to be dysregulated in 
the inflamed mucosa of IBD patients, 
which exhibit hyperplasia, goblet cell 
depletion,  and  enhanced  apoptosis. 
More severe damage may manifest as 
either  total  epithelial  destruction  and 
ulceration, or dysplasia and progressive 
tumorigenesis. Because IECs and intes-
tinal  leukocytes  both  express  PRRs, 
downstream signaling has the potential 
to affect epithelial homeostasis at sev-
eral levels.
A  landmark  study  using  a  mouse 
colitis model in which dextran sodium 
sulfate  (DSS)  acutely  damages  the   
intestinal epithelium demonstrated that 
Myd88
/ mice (deficient in Toll-like 
receptor [TLR], interleukin 1 recep-
tor  [IL-1R],  and  IL-18R  signaling)   
develop  significantly  enhanced  dis-
ease  compared  with  wild-type  mice   
(Rakoff-Nahoum et al., 2004). In this 
context, innate signals are clearly pro-
tective and promote epithelial integrity 
via several mechanisms. These include 
the induction of antiapoptotic and cyto-
protective factors and the promotion   
of tight junction formation (Rakoff- 
Nahoum  et  al.,  2004;  Cario  et  al., 
2007;  Kim  et  al.,  2009).  Moreover, 
microbial sensing by PRRs drives the 
recruitment  of  stromal  and  myeloid 
cells to the ISC niche, thereby facilitat-
ing regeneration of the epithelium after 
injury (Pull et al., 2005; Brown et al., 
2007). In addition to facilitating epi-
thelial  renewal,  PRR  activation  may 
limit bacterial translocation by induc-
ing  the  production  of  antimicrobial 
peptides, such as defensins and RegIII, 
by IECs (Kobayashi et al., 2005; Brandl 
et al., 2007; Nenci et al., 2007). These 
functions  are  partially  mediated  by   
activation of NF-B– and PI3-Akt– 
dependent pathways in IECs (for review 
see Cario, 2008). For example, mice 
whose IECs lack NEMO (NEMO
IEC-KO,   
a  component  of  the  IB  kinase  re-
quired for NF-B activation, develop 
spontaneous  intestinal  inflammation 
(Nenci et al., 2007).
Inflammatory bowel disease (IBD) is characterized by dysregulated immune 
responses to the intestinal microbiota, and by chronic intestinal inflamma-
tion. Several recent studies demonstrate the importance of innate microbial 
recognition by immune and nonimmune cells in the gut. Paradoxically, either 
diminished or exacerbated innate immune signaling may trigger the break-
down of intestinal homeostasis, leading to IBD and colitis-associated cancer 
(CAC). This dichotomy may reflect divergent functional roles for immune 
sensing in intestinal epithelial cells and leukocytes, which may vary with 
distinct disease mechanisms.
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microbiota-driven  inflammatory  re-
sponse  mediated  by  tissue-resident 
leukocytes. This notion is supported 
by the spontaneous colitis that occurs 
in Nemo
IEC-KO mice, in which tumor   
necrosis  factor  produced  by  MyD88- 
activated myeloid cells is thought to 
drive epithelial apoptosis (Nenci et al., 
2007). In contrast, acute epithelial dis-
ruption by DSS or C. rodentium infection 
may  be  a  primary  pathophysiological 
mechanism,  with  gross  disruption  of 
the  epithelium  allowing  MyD88- 
independent  activation  by  the  intes-
tinal  microbiota.  In  this  acute  disease 
setting,  the  epithelial  repair  functions 
of MyD88 play a protective role, pro-
moting restoration of epithelial barrier 
function and a return to homoeostasis. 
It will be of interest to extend studies 
of  inflammasome  function  to  chronic 
colitis models with distinct pathophysi-
ological mechanisms.
Tumorigenesis
Intestinal  tumorigenesis  is  intimately 
linked to intestinal inflammation, and 
by  extension  to  microbial  sensing  by 
PRRs. Intestinal tumors may originate 
from  dysplastic  epithelial  or  intestinal 
stem cells, and are infiltrated by several 
cell types, including lymphoid and my-
eloid cells (Terzic et al., 2010). Evidently, 
as  in  models  of  colitis,  in  models  of 
CAC, PRR signals may modulate the 
neoplastic  and  infiltrating  leukocyte 
populations distinctly, complicating the 
dissection of their role in CAC patho-
physiology. Several previous studies have 
indicated that signals mediated by the 
TLR/IL-1R family promote intestinal 
tumorigenesis. For example, TLR4 is up-
regulated  in  both  human  and  mouse 
neoplastic lesions of the inflamed intes-
tine and promotes CAC in mice treated 
with the chemical procarcinogen azoxy-
methane  (AOM)  followed  by  DSS   
(Fukata et al., 2007). In addition, the size 
and  frequency  of  adenocarcinomas  in   
Apc
Min+/ mice, which express a mutant 
version  of  the  tumor  suppressor  gene 
APC,  are  greater  than  in  Apc
Min+/ 
MyD88
/ mice (Rakoff-Nahoum and 
Medzhitov,  2007).  Moreover,  Il10
/ 
mice treated with AOM develop MyD88-
dependent CAC (Uronis et al., 2009).
IL-1R family signals limit colitis is that 
induced by the attaching and effacing 
bacterium Citrobacter rodentium. Indeed, 
increased numbers of mucosally associ-
ated  adherent-invasive  Escherichia  coli 
have been reported in CD and UC   
patients  (Rolhion  and  Darfeuille- 
Michaud,  2007).  Infected  Myd88
/ 
mice exhibit delayed neutrophil recruit-
ment and enhanced bacterial outgrowth 
in the intestinal mucosa with pronounced 
ulceration,  bleeding,  and  mortality 
(Lebeis  et  al.,  2007;  Gibson  et  al., 
2008a). In this context, dysregulated 
epithelial restitution and repair is com-
pounded by pathogen outgrowth and 
further  immune  activation.  However, 
some PRRs may contribute more to   
immune pathology than to protective 
immunity. For example, Tlr4
/ mice 
develop protective immunity to C. roden-
tium, but develop less severe intestinal pa-
thology than infected wild-type mice 
(Khan et al., 2006). This pathogenic role 
of TLR4 contrasts with that of TLR2 and 
IL-1R, which both limit C. rodentium–
induced inflammation (Gibson et al., 
2008b; Lebeis et al., 2009).
Chronic inflammation
These broadly protective roles for gut 
TLR and inflammasome signals in acute 
intestinal inflammation contrast starkly 
with pathogenic roles played by these 
signals in the Il10
/or Helicobacter he-
paticus–induced chronic colitis models. 
MyD88  signaling  promotes  spontane-
ous  colitis  in  both  Il10
/mice  and 
LysM
Stat3KO  mice;  the  latter  mice  are 
rendered hyporesponsive to IL-10 by a 
myeloid cell–specific deletion of Stat3 
(Kobayashi  et  al.,  2003;  Rakoff- 
Nahoum et al., 2006). Moreover, we 
have recently shown that colitis induced 
by H. hepaticus colonization of RAG
/ 
mice  requires  MyD88  expression  by 
hematopoietic  cells  (Asquith  et  al., 
2010). Together, these findings suggest 
that a failure to regulate TLR/IL-1R 
family–dependent activation of myeloid 
cells  in  the  presence  of  a  triggering   
microbiota can precipitate chronic in-
testinal inflammation.
A key difference in these chronic 
colitis models is that damage to the 
epithelium is likely secondary to the   
Recent studies also support a role 
for NOD-like receptor (NLR)–mediated 
inflammasome activation in maintain-
ing  epithelial  integrity  (Allen  et  al., 
2010;  Dupaul-Chicoine  et  al.,  2010; 
Zaki et al., 2010). Nlrp3
/, Pycard
/, 
and  Casp-1
/  mice,  which  lack  the   
inflammasome  signaling  components 
Nlrp3, Asc, and caspase-1, respectively, 
all exhibit enhanced DSS-induced coli-
tis  compared  with  wild-type  controls 
(Allen  et  al.,  2010;  Dupaul-Chicoine   
et al., 2010; Zaki et al., 2010). These 
findings are consistent with a protective 
role for NLR signaling in this model, 
analogous to that of MyD88 signaling. 
Indeed, because microbial stimuli and 
host danger signals, such as uric acid, 
extracellular ATP, and reactive oxygen 
species, synergize to activate the inflam-
masome  (Franchi  et  al.,  2009),  acute 
epithelial  damage  in  the  microbe- 
rich gut may create a potent niche for 
such regulation.  However,  the  ques-
tion of whether inflammasome activa-
tion in epithelial or hematopoietic cells 
confers  this  protection  has  produced 
mixed  findings  (Allen  et  al.,  2010;   
Dupaul-Chicoine  et  al.,  2010;  Zaki   
et al., 2010).
A  major  effector  function  of   
inflammasome-mediated  activation  of 
caspase-1  is  the  processing  of  pro– 
IL-1 and pro–IL-18 into their active 
forms. Tellingly, Il1r
/, Il18r
/, and 
Il18
/  mice  exhibit  enhanced  DSS- 
induced  colitis  compared  with  wild-
type controls (Takagi et al., 2003; Lebeis 
et al., 2009; Salcedo et al., 2010), and 
recombinant  IL-18  can  attenuate  dis-
ease  (Dupaul-Chicoine  et  al.,  2010; 
Zaki et al., 2010), supporting a role for 
inflammasome-derived  mediators  in 
epithelial  repair.  Crucially,  because 
MyD88 is a signaling adaptor shared by 
IL-1R, IL-18R, and TLRs, its indirect 
activation by NLRs and/or direct acti-
vation by TLRs may be a key event in 
the  restoration  of  epithelial  function. 
Nonetheless, the role of IL-1 and IL-18 
in intestinal inflammation remains con-
tentious, given that earlier studies sup-
port a pathogenic role of these cytokines 
(for review see Siegmund, 2002).
A  comparable  and  perhaps  more 
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tive epithelial repair responses may also 
drive tumorigenesis.
PRR  signals  may  also  modulate 
tumorigenesis independently of their 
pathogenic and protective roles in in-
flammation.  This  is  exemplified  by 
Apc
Min+/mice, which model familial 
adenomatous polyposis patients with 
mutations in the APC gene who de-
velop intestinal polyps and colorectal 
cancer early in life. TLR-MyD88 sig-
nals  promote  tumorigenesis  in  these 
mice, partially through stabilization of 
oncoprotein  c-Myc,  which  induces 
epithelial  hyperproliferation  and  in-
hibits apoptosis (Lee et al., 2010). In 
this case, the presence of a genetic le-
sion such as APC mutations may di-
vert the homeostatic function of PRR 
signaling toward tumorigenesis.
Concluding remarks
Functional analyses of PRR pathways 
in intestinal homeostasis have revealed 
a complex picture with evidence for 
both protective and pathogenic roles. 
Optimally, PRR-signaling should be 
maintained at a homeostatic level at 
which tissue repair and host defense 
are  preserved  (Fig.  1).  Beyond  this 
middle  ground,  immune  pathology 
can result from either impaired or ex-
uberant PRR responses. A key chal-
lenge now is to translate these diverse 
functions of PRR in different animal 
models  to  determine  which  patho-
physiological  mechanisms  underpin 
distinct forms of IBD and CAC. For 
example,  ablation  of  PRR-driven 
leukocyte activation may limit patho-
genesis  in  some  settings,  but  may 
prove  futile,  and  even  exacerbate 
symptoms,  if  barrier  dysfunction  is 
the primary disease mechanism. Care-
ful dissection of PRR-signaling net-
works in different cellular compartments 
and in acute and chronic models of 
intestinal  inflammation  is  an  impor-
tant  first  step  in  designing  rational 
therapeutic  strategies  designed  to   
restore PRR-mediated intestinal ho-
meostasis in IBD.
We thank Michael Barnes for critical reading of the 
manuscript.
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DSS  exhibit  down-regulation  of  mul-
tiple DNA repair genes and have a higher   
frequency of mutations in the oncopro-
tein -catenin, specifically in the domain 
required to target the protein for degra-
dation. This indicates that failed repair of 
DNA damage in MyD88
/ mice may 
render epithelial cells prone to deregula-
tion of the cell cycle and tumor progres-
sion,  despite  their  increased  propensity 
for  cell  death.  Nonetheless,  untreated 
Myd88
/  mice  exhibit  “normal”  ex-
pression of DNA repair genes (Salcedo   
et  al.,  2010),  suggesting  that  this  is  a 
downstream effect of enhanced inflam-
mation in these mice.
Excessive  TLR/IL-1R–driven  sig-
naling  can  itself  drive  proinflammatory 
responses  that  fuel  tumorigenesis,  as 
shown by the MyD88-dependent devel-
opment of CAC in Il10
/ mice treated 
with AOM (Uronis et al., 2009). More-
over, the removal of negative regulators 
of TLR/IL-1R family and inflammasome 
signaling,  such  as  Tir8  or  caspase-12,   
respectively, also leads to increased coli-
tis  and  CAC  in  the  DSS  +  AOM 
model (Dupaul-Chicoine et al., 2010;   
Garlanda et al., 2007). In addition to   
excessive production of inflammatory   
cytokines in these mice, hyperprolifera-
In contrast to the tumorigenic role 
of TLR4 signals in the DSS + AOM 
model,  the  Nlrp3  inflammasome  and 
MyD88  signals  prevent  CAC  in  this 
setting.  This  paradox  remains  unre-
solved.  However,  whereas  epithelial 
TLR4 signals promote tumorigenesis 
(Fukata  et  al.,  2009),  hematopoietic 
Nlrp3 activation may be required for 
protection  (Allen  et  al.,  2010).  Thus, 
distinct  compartmentalized  roles  may 
underscore  these  divergent  functions. 
Alternatively,  MyD88-independent 
TLR4  signaling  through  the  adaptor 
TRIF may play a role, and merits fur-
ther investigation.
When treated with DSS, MyD88
/ 
(Fukata  et  al.,  2005;  Rakoff-Nahoum   
et  al.,  2004),  Nlrp3
/,  and  Casp-1
/ 
mice exhibit enhanced epithelial apop-
tosis  and  diminished  or  comparable   
epithelial  proliferation  relative  to  DSS- 
treated wild-type mice (Zaki et al., 2010). 
Rather  counterintuitively,  MyD88
/, 
Nlrp3
/, and Casp-1
/ mice show 
enhanced tumorigenesis compared with   
wild-type  mice  if  also  treated  with 
AOM  (Allen  et  al.,  2010;  Salcedo   
et al., 2010). A possible explanation pro-
vided  by  Salcedo  et  al.  (2010)  is  that 
MyD88
/ mice treated with AOM + 
Figure 1.  Diminished or enhanced intestinal PRR signals may promote intestinal inflam-
mation and tumorigenesis. PRR signals are maintained at a critical threshold to maintain intes-
tinal homeostasis. PRR signals may be required to restore barrier function after epithelial insult 
and for protective immunity against pathogens; impairment of these processes caused by insuf-
ficient PRR signaling may result in pathogen outgrowth and, indirectly, excessive subsequent 
inflammation (left). Excessive PRR-driven repair or inflammatory responses (right) may also 
threaten homeostasis, e.g., through dysregulated epithelial proliferation leading to tumorigenesis 
and overexuberant pathogenic inflammatory responses to the intestinal microbiota.1576 Innate microbial sensing in colitis and cancer  | Asquith and Powrie
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